…
Positron Corporation, a medical technology company, co-develops, manufactures, and sells positron emission tomography and PET-computed tomography imaging systems in the United States. The company offers Attrius PET and NeuSight PET-CT 64-slice used in non-invasive diagnosis and evaluation of coronary artery disease and supports various molecular imaging applications, including cardiology, oncology, and neurology. It also provides clinical and technical support services, such as physician interpretation training, nurse and technologist training, billing and prior-authorization assistance, physician over-read services, 24/7 clinical and technical support, priority response with after-hours service availability, equipment uptime guarantees and software upgrades, and remote system diagnostics and maintenance capabilities. The company sells its products through internal sales and marketing team. It serves healthcare providers, imaging centers, hospitals, and cardiology practices. The company was incorporated in 1983 and is headquartered in North Tonawanda, New York.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -10.60M | -2.39M | -1.64M | -2.86M | -0.60M |
| Net income | -10.60M | -2.39M | -1.64M | -2.86M | -0.60M |
| Selling general administrative | 8.38M | 1.86M | - | - | - |
| Gross profit | -2.11M | -0.34M | -0.35M | -0.08M | 0.13M |
| Reconciled depreciation | 0.05M | 0.04M | - | - | - |
| Ebit | -10.50M | -2.21M | -1.49M | -2.81M | -0.60M |
| Ebitda | -10.44M | -2.18M | -1.45M | -2.77M | -0.57M |
| Depreciation and amortization | 0.05M | 0.04M | 0.04M | 0.04M | 0.03M |
| Operating income | -10.50M | -2.21M | -1.36M | -2.68M | -0.76M |
| Other operating expenses | 10.96M | 2.80M | 2.10M | 3.41M | 1.65M |
| Interest expense | 0.13M | 0.17M | 0.28M | 0.05M | - |
| Interest income | 0.04M | 0.00M | - | - | - |
| Net interest income | -0.09M | -0.17M | - | - | - |
| Income tax expense | - | - | 0.00M | -0.00M | 0.00M |
| Total revenue | 0.46M | 0.59M | 0.73M | 0.73M | 0.88M |
| Total operating expenses | 8.38M | 1.87M | 1.01M | 2.60M | 0.90M |
| Cost of revenue | 2.58M | 0.93M | 1.09M | 0.81M | 0.75M |
| Total other income expense net | -0.10M | -0.17M | -0.28M | -0.18M | 0.17M |
| Net income from continuing ops | -10.60M | -2.38M | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 4.00M | 1.80M | 1.77M | 1.77M | 1.96M |
| Other current assets | 0.13M | 0.01M | 0.00M | 0.00M | 0.00M |
| Total liab | 2.56M | 2.21M | 2.03M | 1.89M | 0.34M |
| Total stockholder equity | 1.44M | -0.41M | -0.26M | -0.12M | 1.62M |
| Other current liab | - | - | 0.00M | - | - |
| Common stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Capital stock | 0.00M | 0.63M | - | - | - |
| Retained earnings | -144.94M | -134.09M | -131.70M | -129.31M | -127.00M |
| Other assets | - | 0.00M | 0.00M | - | 0.00M |
| Cash | 2.52M | 0.07M | 0.10M | 0.07M | 1.41M |
| Total current liabilities | 2.40M | 2.19M | 1.98M | 1.83M | 0.34M |
| Current deferred revenue | 0.12M | 0.07M | 0.02M | 0.02M | 0.02M |
| Net debt | -0.57M | 1.73M | 1.69M | 1.47M | -1.10M |
| Short term debt | 1.79M | 1.78M | 1.74M | 1.49M | 0.32M |
| Short long term debt | 1.76M | 2.01M | - | - | - |
| Short long term debt total | 1.95M | 1.80M | 1.79M | 1.54M | 0.32M |
| Other stockholder equity | 146.38M | 133.05M | 130.82M | 129.31M | 128.00M |
| Total current assets | 3.34M | 1.35M | 1.38M | 1.34M | 1.64M |
| Net receivables | 0.01M | 0.02M | 0.02M | 0.01M | 0.02M |
| Inventory | 0.68M | 1.26M | 1.26M | 1.26M | 0.20M |
| Accounts payable | 0.49M | 0.34M | 0.21M | 0.33M | 0.01M |
| Accumulated other comprehensive income | 0.00M | - | -0.00M | -0.00M | -0.00M |
| Non currrent assets other | 0.37M | 0.37M | 0.27M | 0.28M | 0.21M |
| Non current assets total | 0.66M | 0.45M | 0.39M | 0.43M | 0.33M |
| Capital lease obligations | 0.18M | 0.04M | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total cashflows from investing activities | -0.10M | - | - | - | -0.09M |
| Net borrowings | -0.25M | 0.30M | - | - | - |
| Total cash from financing activities | 7.25M | 1.70M | 1.62M | 1.20M | 2.10M |
| Net income | -10.60M | -2.39M | -1.64M | -2.86M | -0.60M |
| Change in cash | 2.45M | -0.03M | 0.03M | -1.34M | 1.39M |
| Begin period cash flow | 0.07M | 0.10M | 0.07M | 1.41M | 0.03M |
| End period cash flow | 2.52M | 0.07M | 0.10M | 0.07M | 1.41M |
| Total cash from operating activities | -4.70M | -1.73M | -1.60M | -2.54M | -0.62M |
| Issuance of capital stock | 10.00M | 1.40M | - | - | - |
| Depreciation | 0.05M | 0.04M | 0.04M | 0.04M | 0.03M |
| Other cashflows from investing activities | - | - | -0.00M | - | - |
| Change to inventory | - | - | - | -1.26M | -0.08M |
| Change to account receivables | 0.01M | 0.01M | -0.01M | 0.01M | 0.02M |
| Sale purchase of stock | -2.50M | 0.00M | - | - | - |
| Other cashflows from financing activities | - | - | -0.25M | - | -0.09M |
| Capital expenditures | 0.10M | 0.00M | 0.00M | 0.00M | 0.09M |
| Change in working capital | 0.11M | 0.05M | -0.13M | -1.00M | -0.10M |
| Stock based compensation | 4.98M | 0.00M | - | - | - |
| Other non cash items | 5.73M | 0.56M | 0.13M | 1.28M | 0.05M |
| Free cash flow | -4.80M | -1.73M | -1.60M | -2.54M | -0.71M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| POSC Positron Corp |
-0.04 2.48% |
1.57 | - | 103.09 | 131.43 | 370.36 | 134.98 | -4.12 |
| ABT Abbott Laboratories |
-0.10 0.10% |
103.87 | 25.97 | 17.24 | 3.57 | 3.20 | 3.81 | 16.75 |
| MDT Medtronic PLC |
- -% |
100.61 | 26.60 | 15.87 | 3.35 | 2.08 | 3.90 | 14.12 |
| SYK Stryker Corporation |
-0.13 0.04% |
313.08 | 29.23 | 16.86 | 4.18 | 4.51 | 4.63 | 17.16 |
| SEMHF Siemens Healthineers AG |
0.64 1.35% |
48.14 | 39.57 | 21.32 | 3.01 | 3.29 | 2.95 | 16.92 |
Positron Corporation, a medical technology company, co-develops, manufactures, and sells positron emission tomography and PET-computed tomography imaging systems in the United States. The company offers Attrius PET and NeuSight PET-CT 64-slice used in non-invasive diagnosis and evaluation of coronary artery disease and supports various molecular imaging applications, including cardiology, oncology, and neurology. It also provides clinical and technical support services, such as physician interpretation training, nurse and technologist training, billing and prior-authorization assistance, physician over-read services, 24/7 clinical and technical support, priority response with after-hours service availability, equipment uptime guarantees and software upgrades, and remote system diagnostics and maintenance capabilities. The company sells its products through internal sales and marketing team. It serves healthcare providers, imaging centers, hospitals, and cardiology practices. The company was incorporated in 1983 and is headquartered in North Tonawanda, New York.
3784 Commerce Court, North Tonawanda, NY, United States, 14120
727 287 2800
10
| Name | Title | Year Born |
|---|---|---|
| Mr. Adel Abdullah | Pres & Director | NA |
| Mr. Adel Abdullah | President & Chairman | 1974 |
| Mr. Aaron Hargrave | Vice President | 1986 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.